FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a combination containing the mTOR inhibitor everolimus and vinorelbine applicable for simultaneous, combined, separate or successive introduction.
EFFECT: invention refers to a method for preventing or treating a proliferative disease.
8 cl, 6 dwg, 2 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TREATING NEUROENDOCRINE TUMOURS | 2006 |
|
RU2487711C2 |
| COMBINATIONS OF HSP90 INHIBITOR | 2009 |
|
RU2519673C2 |
| APPLICATION OF RAPAMYCIN DERIVATIVE | 2013 |
|
RU2659725C2 |
| APPLICATION OF RAPAMYCIN DERIVATIVE | 2013 |
|
RU2665138C2 |
| COMBINATIONS OF THERAPEUTIC AGENTS FOR CANCER TREATMENT | 2007 |
|
RU2449788C2 |
| COMBINATION AND METHOD FOR PROPHYLAXIS OF BREAST CANCER | 2002 |
|
RU2322981C2 |
| USE OF RAPAMYCIN DERIVATIVE | 2011 |
|
RU2483727C1 |
| INHIBITION OR PREVENTION OF DISTURBED ANGIOGENIC REGULATION WITH USING RAPAMYCIN DERIVATIVES, AND PHARMACEUTICAL COMPOSITIONS CONTAINING RAPAMYCIN DERIVATIVE | 2006 |
|
RU2445093C2 |
| TREATING TUBEROUS SCLEROSIS | 2007 |
|
RU2473343C2 |
| CANCER MEDICAL TREATMENT | 2005 |
|
RU2325906C2 |
